|
EP1912724A2
(en)
*
|
2005-07-28 |
2008-04-23 |
Global Research Technologies, LLC |
Removal of carbon dioxide from air
|
|
US20130172274A1
(en)
|
2005-12-20 |
2013-07-04 |
Duke University |
Methods and compositions for delivering active agents with enhanced pharmacological properties
|
|
US8841255B2
(en)
|
2005-12-20 |
2014-09-23 |
Duke University |
Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
|
|
CN101384272B
(zh)
|
2005-12-20 |
2013-05-01 |
杜克大学 |
用于递送具有增强的药理性质的活性剂的方法和组合物
|
|
US7709227B2
(en)
*
|
2006-01-04 |
2010-05-04 |
Phasebio Pharmaceuticals, Inc. |
Multimeric ELP fusion constructs
|
|
EP2004813B1
(en)
|
2006-04-03 |
2015-06-03 |
Promega Corporation |
Permuted and nonpermuted luciferase biosensors binding cyclic nucleotides
|
|
EP2281046B1
(en)
|
2008-05-19 |
2012-01-25 |
Promega Corporation |
LUCIFERASE BIOSENSORS FOR cAMP
|
|
EP3412300A1
(en)
|
2008-06-27 |
2018-12-12 |
Duke University |
Therapeutic agents comprising elastin-like peptides
|
|
WO2010004265A1
(en)
|
2008-07-07 |
2010-01-14 |
Oxford Nanopore Technologies Limited |
Enzyme-pore constructs
|
|
JP2011527191A
(ja)
|
2008-07-07 |
2011-10-27 |
オックスフォード ナノポア テクノロジーズ リミテッド |
塩基検出細孔
|
|
GB0820927D0
(en)
|
2008-11-14 |
2008-12-24 |
Isis Innovation |
Method
|
|
CN101418290A
(zh)
*
|
2008-12-02 |
2009-04-29 |
中山大学 |
一种高效的elp融合蛋白酶及其制备和应用
|
|
US8214916B2
(en)
|
2009-01-26 |
2012-07-03 |
Nanoink, Inc. |
Large area, homogeneous array fabrication including leveling with use of bright spots
|
|
US20120100530A1
(en)
*
|
2009-01-30 |
2012-04-26 |
Oxford Nanopore Technologies Limited |
Enzyme mutant
|
|
JP5843614B2
(ja)
|
2009-01-30 |
2016-01-13 |
オックスフォード ナノポア テクノロジーズ リミテッド |
膜貫通配列決定における核酸構築物のためのアダプター
|
|
GB0905140D0
(en)
|
2009-03-25 |
2009-05-06 |
Isis Innovation |
Method
|
|
WO2010124180A1
(en)
*
|
2009-04-23 |
2010-10-28 |
Phasebio Pharmaceuticals, Inc. |
Phenylalanine hydroxylase fusion protein and methods for treating phenylketonuria
|
|
DK3311828T3
(da)
*
|
2009-08-14 |
2021-06-28 |
Phasebio Pharmaceuticals Inc |
Modificerede vasoaktive tarmpeptider
|
|
US8940868B2
(en)
*
|
2009-10-08 |
2015-01-27 |
The General Hospital Corporation |
Elastin based growth factor delivery platform for wound healing and regeneration
|
|
US9035028B2
(en)
*
|
2010-03-10 |
2015-05-19 |
Emory University |
Temperature sensitive conjugate compositions
|
|
US9290794B2
(en)
|
2010-05-11 |
2016-03-22 |
Promega Corporation |
Mutant protease biosensors with enhanced detection characteristics
|
|
EP3508570B1
(en)
*
|
2010-05-11 |
2020-07-22 |
Promega Corporation |
Mutant protease biosensors with enhanced detection characteristics
|
|
CN101955960B
(zh)
*
|
2010-08-03 |
2012-05-23 |
中山大学 |
一种利用类弹性蛋白标签纯化重组乳糖酶的方法
|
|
CA2827170A1
(en)
|
2011-02-11 |
2012-08-16 |
David M. Hilbert |
Monovalent and multivalent multispecific complexes and uses thereof
|
|
AU2012215135B9
(en)
|
2011-02-11 |
2017-03-09 |
Oxford Nanopore Technologies Limited |
Mutant pores
|
|
WO2012170524A1
(en)
|
2011-06-06 |
2012-12-13 |
Phasebio Pharmaceuticals, Inc. |
Use of modified vasoactive intestinal peptides in the treatment of hypertension
|
|
CN102241747A
(zh)
*
|
2011-06-17 |
2011-11-16 |
李立文 |
类人弹性蛋白及其生产方法
|
|
AU2012288629B2
(en)
|
2011-07-25 |
2017-02-02 |
Oxford Nanopore Technologies Limited |
Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
|
|
WO2013016578A2
(en)
*
|
2011-07-26 |
2013-01-31 |
University Of Southern California |
Controlled release of ocular biopharmaceuticals using bioresponsive protein polymers
|
|
CA2846209C
(en)
*
|
2011-08-24 |
2022-04-05 |
Phasebio Pharmaceuticals, Inc. |
Systemic sustained release formulation comprising elastinlike peptide repeating sequence and protein active agent
|
|
WO2013120022A2
(en)
*
|
2012-02-08 |
2013-08-15 |
Seneb Biosciences, Inc. |
Treatment of hypoglycemia
|
|
US20130210747A1
(en)
|
2012-02-13 |
2013-08-15 |
University Of Southern California |
Methods and Therapeutics Comprising Ligand-Targeted ELPs
|
|
JP6157877B2
(ja)
*
|
2012-02-28 |
2017-07-05 |
三洋化成工業株式会社 |
組織再生用ゲル、組織再生用タンパク質溶液及び組織再生用ゲルの製造方法
|
|
JP6271505B2
(ja)
|
2012-04-10 |
2018-01-31 |
オックスフォード ナノポール テクノロジーズ リミテッド |
変異体ライセニンポア
|
|
US11155860B2
(en)
|
2012-07-19 |
2021-10-26 |
Oxford Nanopore Technologies Ltd. |
SSB method
|
|
US20150218280A1
(en)
|
2012-08-10 |
2015-08-06 |
University Of Southern California |
CD20 scFv-ELPs METHODS AND THERAPEUTICS
|
|
WO2014028776A1
(en)
*
|
2012-08-15 |
2014-02-20 |
Zyngenia, Inc. |
Monovalent and multivalent multispecific complexes and uses thereof
|
|
JP2016505627A
(ja)
*
|
2013-01-15 |
2016-02-25 |
フェーズバイオ ファーマシューティカルズ，インコーポレイテッド |
治療剤、組成物、および血糖コントロールのための方法
|
|
KR102168813B1
(ko)
|
2013-03-08 |
2020-10-22 |
옥스포드 나노포어 테크놀로지즈 리미티드 |
효소 정지 방법
|
|
GB201314695D0
(en)
|
2013-08-16 |
2013-10-02 |
Oxford Nanopore Tech Ltd |
Method
|
|
GB201313477D0
(en)
|
2013-07-29 |
2013-09-11 |
Univ Leuven Kath |
Nanopore biosensors for detection of proteins and nucleic acids
|
|
EP3785725A1
(en)
*
|
2013-10-01 |
2021-03-03 |
University of Mississippi Medical Center |
Composition and method for therapeutic agent delivery during pregnancy
|
|
WO2015120091A1
(en)
*
|
2014-02-04 |
2015-08-13 |
Duke University |
Systems and devices for protease detection based on engineered polymers and biopolymers and methods of use
|
|
GB201403096D0
(en)
|
2014-02-21 |
2014-04-09 |
Oxford Nanopore Tech Ltd |
Sample preparation method
|
|
DK3145530T3
(da)
|
2014-04-21 |
2021-06-14 |
D&D Pharmatech Inc |
Trail receptor agonists for treatment of fibrotic diseases
|
|
US10443097B2
(en)
|
2014-05-02 |
2019-10-15 |
Oxford Nanopore Technologies Ltd. |
Method of improving the movement of a target polynucleotide with respect to a transmembrane pore
|
|
WO2015172046A1
(en)
|
2014-05-08 |
2015-11-12 |
Phasebio Pharmaceuticals, Inc. |
Methods and compositions for treating cystic fibrosis
|
|
US10400014B2
(en)
|
2014-09-01 |
2019-09-03 |
Oxford Nanopore Technologies Ltd. |
Mutant CsgG pores
|
|
US10266885B2
(en)
|
2014-10-07 |
2019-04-23 |
Oxford Nanopore Technologies Ltd. |
Mutant pores
|
|
GB201418159D0
(en)
|
2014-10-14 |
2014-11-26 |
Oxford Nanopore Tech Ltd |
Method
|
|
JP7075757B2
(ja)
*
|
2014-11-21 |
2022-05-26 |
フェーズバイオ ファーマシューティカルズ，インコーポレイテッド |
制御放出および持続的放出のためのｅｌｐ融合タンパク質
|
|
CA2970478A1
(en)
|
2014-12-10 |
2016-06-16 |
S-Aima Holding Company, Llc |
Generation of hemoglobin-based oxygen carriers using elastin-like polypeptides
|
|
CA2976038A1
(en)
|
2015-02-09 |
2016-08-18 |
Phasebio Pharmaceuticals, Inc. |
Methods and compositions for treating muscle disease and disorders
|
|
WO2017020025A1
(en)
*
|
2015-07-29 |
2017-02-02 |
Kiick Kristi |
Thermoresponsive bioconjugates and their controlled delivery of cargo
|
|
CN106632682A
(zh)
*
|
2015-08-04 |
2017-05-10 |
清华大学 |
融合蛋白ifn-elp及其应用
|
|
JP6882782B2
(ja)
*
|
2015-08-04 |
2021-06-02 |
デューク ユニバーシティ |
遺伝子コードされた本質的に無秩序な送達用ステルスポリマーおよびその使用方法
|
|
KR101759122B1
(ko)
|
2015-08-07 |
2017-07-18 |
계명대학교 산학협력단 |
오렉신 a를 함유하는 당뇨병 치료용 약학 조성물
|
|
WO2017106627A1
(en)
|
2015-12-17 |
2017-06-22 |
The Johns Hopkins University |
Ameliorating systemic sclerosis with death receptor agonists
|
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
|
WO2017159915A1
(ko)
|
2016-03-14 |
2017-09-21 |
한양대학교 에리카산학협력단 |
상 전이 거동을 가지는 폴리펩타이드, 상기 폴리펩타이드-칼모듈린-폴리펩타이드의 다중-자극 반응성을 가지는 삼중 블럭 폴리펩타이드, 상기 삼중 블럭 폴리펩타이드로 제조된 하이드로젤 및 상기 하이드로젤의 용도
|
|
KR102028931B1
(ko)
*
|
2016-03-24 |
2019-10-08 |
한양대학교 에리카산학협력단 |
지능형 약물 전달을 위한 다중 자극 반응성을 지닌 칼모듈린-엘라스틴 이중 블럭 폴리펩타이드의 동적 나노 전달체 및 제조방법
|
|
KR102508650B1
(ko)
|
2016-04-07 |
2023-03-13 |
더 존스 홉킨스 유니버시티 |
사멸 수용체 작용제로써 췌장암 및 통증을 치료하기 위한 조성물 및 방법
|
|
ES2909074T3
(es)
|
2016-05-06 |
2022-05-05 |
Phasebio Pharmaceuticals Inc |
Proteínas de fusión ELP para liberación controlada y sostenida
|
|
GB201609220D0
(en)
|
2016-05-25 |
2016-07-06 |
Oxford Nanopore Tech Ltd |
Method
|
|
WO2017210476A1
(en)
|
2016-06-01 |
2017-12-07 |
Duke University |
Nonfouling biosensors
|
|
CN107459580A
(zh)
*
|
2016-06-06 |
2017-12-12 |
易金阳 |
一种利用酵母菌表达含有穿膜肽的寡肽‑1（egf）创新制备工艺
|
|
RU2019110848A
(ru)
|
2016-09-14 |
2020-10-15 |
Дьюк Юниверсити |
Наночастицы на основе триблочных полипептидов для доставки гидрофильных лекарственных средств
|
|
EP3515928B1
(en)
|
2016-09-23 |
2026-01-28 |
Duke University |
Unstructured non-repetitive polypeptides having lcst behavior
|
|
CN106519040B
(zh)
*
|
2016-11-02 |
2020-03-27 |
南京大学 |
一种含肿瘤坏死因子相关凋亡诱导配体的融合蛋白和其制备方法及由该蛋白自组装的纳米粒
|
|
WO2018132732A1
(en)
|
2017-01-12 |
2018-07-19 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
|
KR101955366B1
(ko)
*
|
2017-06-02 |
2019-03-07 |
인제대학교 산학협력단 |
인터페론 베타-엘라스틴 재조합 단백질 및 이의 생산방법
|
|
WO2019006374A1
(en)
|
2017-06-30 |
2019-01-03 |
Duke University |
ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS
|
|
JP7074995B2
(ja)
*
|
2017-10-13 |
2022-05-25 |
林兼産業株式会社 |
線維芽細胞増殖促進剤及び線維芽細胞におけるエラスチン産生促進剤
|
|
US12296018B2
(en)
|
2018-01-26 |
2025-05-13 |
Duke University |
Albumin binding peptide-drug (AlBiPeD) conjugates and methods of making and using same
|
|
CN108531492A
(zh)
*
|
2018-04-23 |
2018-09-14 |
内蒙古农业大学 |
利用类弹性蛋白elp构建活性绵羊β-防御素sbd-1体外表达的方法
|
|
EP3788343B1
(en)
|
2018-04-30 |
2024-03-27 |
Duke University |
Stimuli-responsive peg-like polymer-based drug delivery platform
|
|
GB201807793D0
(en)
|
2018-05-14 |
2018-06-27 |
Oxford Nanopore Tech Ltd |
Method
|
|
EP3829622A4
(en)
|
2018-08-02 |
2022-05-11 |
Duke University |
DOUBLE AGONIST FUSION PROTEINS
|
|
US12269847B2
(en)
|
2018-08-16 |
2025-04-08 |
Donaldson Company, Inc. |
Genetically encoded polypeptide for affinity capture and purification of biologics
|
|
WO2020051541A1
(en)
|
2018-09-07 |
2020-03-12 |
Duke University |
Nanoparticulate drug delivery systems
|
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
|
US20220289812A1
(en)
*
|
2019-08-09 |
2022-09-15 |
Phasebio Pharmaceuticals, Inc. |
Elp fusion proteins comprising parathyroid hormone for controlled and sustained release
|
|
EP4107167A4
(en)
*
|
2020-02-19 |
2024-04-03 |
Donaldson Company, Inc. |
PROTEIN-BASED PURIFICATION MATRIX AND METHODS OF USE
|
|
WO2021202546A1
(en)
|
2020-03-31 |
2021-10-07 |
Cyclerion Therapeutics, Inc. |
Early drug interventions to reduce covid-19 related respiratory distress, need for ventilator assistance and death
|
|
US11767353B2
(en)
|
2020-06-05 |
2023-09-26 |
Theraly Fibrosis, Inc. |
Trail compositions with reduced immunogenicity
|
|
KR102687389B1
(ko)
*
|
2020-08-25 |
2024-07-25 |
한양대학교 에리카산학협력단 |
자극 반응성 및 표면 부착성을 가진 점착성 엘라스틴 및 서커린 기반 다중 블록 코폴리펩타이드, 그의 자가조립 구조체 및 주사형 하이드로겔의 생접착제 응용
|
|
US20220227805A1
(en)
|
2020-12-23 |
2022-07-21 |
Jazz Pharmaceuticals Ireland Ltd. |
Methods of purifying charge-shielded fusion proteins
|
|
CN117279936A
(zh)
*
|
2021-02-19 |
2023-12-22 |
唐纳森公司 |
包含具有相行为的蛋白的融合蛋白
|
|
WO2023225802A1
(zh)
*
|
2022-05-23 |
2023-11-30 |
复旦大学 |
三叶因子2/干扰素α2融合蛋白及其防治病毒感染性疾病的应用
|
|
CN115724915B
(zh)
*
|
2022-08-17 |
2025-08-12 |
上普博源（北京）生物科技有限公司 |
类弹性蛋白多肽粘合剂及其制备方法与应用
|
|
CN117777303A
(zh)
*
|
2022-09-27 |
2024-03-29 |
北京大学 |
一种高亲和力pd1蛋白偶联物及其应用
|
|
EP4644412A1
(en)
*
|
2022-12-27 |
2025-11-05 |
NexThera Co., Ltd. |
Manufacture of elastin-like polypeptide-based recombinant protein and animal cell expression platform thereof
|
|
WO2025076213A1
(en)
*
|
2023-10-04 |
2025-04-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Isothermally phase-separable elastin-like polypeptides, compositions, and methods of use thereof
|
|
WO2025100511A1
(ja)
*
|
2023-11-10 |
2025-05-15 |
地方独立行政法人神奈川県立産業技術総合研究所 |
融合ペプチド
|
|
WO2026005476A1
(ko)
*
|
2024-06-26 |
2026-01-02 |
주식회사 넥스세라 |
혈소판 감소증 치료를 위한 재조합 단백질 및 이의 용도
|